Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Leading protagonists held by police in fight to protect cannabis patients.

Who Are We Hurting?

Article written by Rip Nicholson When kissing a loved one amounts to having your business and your earnings taken from you, two founding members of a pro-cannabis collective have taken their fight to the powers that be and have since been fined by NSW Police for protesting cannabis laws in urgent need of review. Two members of a group of activists asking the question ‘WHO ARE WE HURTING?’ artist Alec “Craze” Zammitt and pro athlete turned entrepreneur and podcaster, William “Willy Biggs” Stolk - jointly known as the Australian ‘Kings of Cannabis’ - have fought on many battlefields for the advocacy of drug reform policy in Australia. Along with Sydney Opera House and harbour bridge projections, the group of activists have worked alongside the Legalise Cannabis Australia Party (formerly the HEMP party) through a series of well-orchestrated and very daring public awareness and guerrilla campaigns and protests which have each proved to be successful. Who Are We Hurting? Australian 420 Protests. The latest ‘Who Are We Hurting?’ installation ‘Opera House laser beam stunt’ as coined by The Daily Telegraph saw the pair projecting pro-cannabis slogans across the famous white sails of the Sydney Opera House and the Sydney Harbour Bridge in the wee hours of 20 April, this year (also known as 420 - the international day to celebrate the cannabis plant). Using industrial projectors to illuminate the question, ‘420’ and dancing cannabis leaf animations across the iconic landmarks, the event was posted and shared throughout social media. How a kiss can get you prosecuted under broken driving legislation. In 2020, Zammitt, a former owner of a private security firm, had his licence to operate his business revoked due to a positive roadside test finding traces of cannabis in his system, thus stripping him of his ability to operate the enterprise. Zammitt along with representation from Mark Davis of Sydney City Crime disputed these results from NSW’s Government’s controversial mobile drug testing program insisting the positive test was most likely caused by cross-contamination by way of intimacy with his partner, a fellow medicinal cannabis patient. After being reviewed by an expert doctor in the field, it was found to be entirely possible that the cannabis detected in Zammitt’s system was picked up from a kiss exchanged with his partner prior to driving the car in which he was tested. Zammitt received two no-convictions for driving with cannabis in his system and was allowed to maintain his driving licence. Despite this, the NSW Police revoked Zammitt’s licence to operate his business. Without further evidence to suggest Zammitt was indeed under the influence of cannabis or any requirement for Zammitt to be removed from the roads, Zammitt believes his vehicle was targeted due to prior protests and his case shines a light on the many flaws present within the mobile roadside drug test systems throughout most Australian states. “This has become a de facto means of drug testing all citizens, and they’re doing it through licensing,” said Mark Davis. “There’s no onus on the police to prove these people were affected by drugs in any way, but you still have hundreds of people ending up with criminal convictions – even for trace elements in their system,” said Davis. 58-year-old Magistrate David Heilpern has retired after 21 years in service after stating he could not in good conscience continue to apply the law as stated and take away licences for drug driving out of his Lismore court — sometimes as many as 30 in a day. David Heilpern has since annonced his involvement as campaign lead for Drive Change, an initiative dedicated to fixing this legislation in Australia. "An enormous number, the vast majority of people who are brought before the courts on this charge, are not affected [by the drug]," says Heilpern. Mr Heilpern says there's not enough evidence to suggest a clear link between a positive test for cannabis and adverse driving, given the minute levels of the drug detected in roadside tests. "When they introduced random breath testing, the road toll decreased massively. When they introduced seatbelt laws, there was a reduction in the road toll,” said Heilpern. “I have seen nothing to show that there is any reduction in the road toll as a result of the thousands and thousands of people who are appearing before courts for historic use of cannabis." Cannabis has been legal in Australia for years now. Doctors at MediCann Clinics, the clinic prescribing Zammitt must advise patients that they cannot legally drive if there is any THC in their system. Clinic founder, Matthew Shales gets first-hand reports of the very real frustrations that come from drug driving laws as they stand. Shales is a committed advocate for his patients’ right to not be discriminated against with the current driving laws in Australia prohibiting cannabis from being present in the system. “Unfortunately, as the rules currently stand, we have to advise our patients that they cannot legally drive if there is any THC in their system, even if they are not impaired,” said Shales. “This has negative impacts for patients by either forcing isolation through not being able to drive or through a heightened level of anxiety for the patients that choose to drive, which is the opposite outcome we are hoping to achieve by prescribing patients medicinal cannabis. NSW Government’s controversial mobile drug testing program has come under scrutiny following a recent study released by the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, comparing the length of time in which someone is likely to be impaired by cannabis to the duration of the time it can be detected in their system. The study found that a user’s impairment is likely to last three to 10 hours but can be detected in the body for weeks after consumption. Currently, a medicinal driving defence amendment - The Road Transport Amendment Bill (Medicinal Cannabis – Exemptions from Offences) Bill, 2021 is before parliament in deliberation with NSW Greens MP, Cate Faehrmann heading up the passing of the Bill in the near future. The strength of which is geared around gathering traction of enough support through the committee report. However, questions remain on what experts are to be heard from and ultimately, who is responsible for the final decision. Here, the fight continues as to whether those who require medical cannabis can be free to drive without fear of a positive roadside drug test. “Current driving laws in Australia are forcing patients to choose between their medicine or their independence. We are trying to improve the quality of life for our patients, yet the ancient driving laws currently in place make it exceedingly hard to do so.” said Shales. Zammitt and Stolk’s current case is not without precedent. Theirs is not dissimilar to that of the 2018 actions of comedy group and tv show The Chasers who projected radio broadcaster Alan Jones phone number alongside "Advertise Here, Call Alan'' on the same very sails of the Opera House on which Zammitt and Stolk would later be charged for ‘advertising’. Despite the widespread media coverage, The Chasers were not investigated by police. Zammitt and Stolk have been issued infringement notices relating to offences that uniquely apply only to the Opera House under obscure legislation known as the Sydney Opera House Trust By-law 2021. Similar legislation titled 2015 applied at the time of The Chasers projection. The maximum fine for the infringements against Zammitt and Stolk is $1,100 for each offence and is set for a hearing on 20 December. Contact Details News Direct Newsroom newsroom@newsdirect.com

July 25, 2022 08:30 AM Eastern Daylight Time

Video Image

YD Capital I L.P. Receives Subscription, Enabling Yidu Tech to Build A Healthcare Intelligence Ecosystem

Yidu Tech Inc.

HONG KONG SAR - Media OutReach - 25 July 2022 - A USD fund——YD Capital I L.P. (the “Fund”) has received subscription from investors including well-known international sovereign wealth funds. The Fund will focus on investments in high-quality enterprises in both upstream and downstream segments of the healthcare intelligence industry, including digital diagnosis and treatment, innovative insurance, pharmaceutical research & development (“R&D”), and health management. It will seek to empower industry stakeholders including healthcare institutions, experts, and pharmaceutical companies through innovative technologies, thereby significantly improving healthcare efficiency and accelerating the realization and enhancement of "effectiveness, accessibility, and inclusiveness", three qualities that form the healthcare industry’s “Golden Triangle”. As a leading company in China's healthcare intelligence industry, Yidu Tech Inc. ("Yidu Tech", HKEx: 2158) is committed to building a healthcare intelligence ecosystem. Ms. Yang Jing, Executive Director, President and Chief Financial Officer of Yidu Tech, remarked, “Technology innovation is the driving force behind the healthcare industry’s continuous development. Yidu Tech will fully capitalize on our competitive advantages as a healthcare intelligence leader, including our technical capabilities, medical network, and expert resources. Through promoting the cooperation of The Fund, Yidu Tech will collaborate with industry stakeholders around the globe to realize synergies,promote the transformation of scientific and technological achievements, and enhance the efficiency of R&D and treatments. In this way, we will accelerate the transformation of the industry and realize our vision of ‘safer, better, and more accessible’ green healthcare.” About Yidu Tech Inc. Founded in 2014, Yidu Tech Inc. ("Yidu Tech", stock code: 2158.HK) has been focusing on the development and application of healthcare intelligence since its inception. The Group focuses on solving the pain points of intelligent applications in the three major healthcare scenarios of public health, research, and diagnosis and treatment, empowering the industry through healthcare intelligence infrastructure, and promoting the construction of a safe, accessible, and value-based healthcare system. In January 2021, Yidu Tech was successfully listed on the Main Board of the Hong Kong Stock Exchange. Yidu Tech primarily operates in three business segments, namely Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions, which facilitate medical and clinical research, health management, public health management and development of innovative drugs, as well as assist the industry in reducing cost and improving efficiency, with an aim to make value-based precision healthcare accessible to everyone. Contact Details Christensen Advisory Jenny Lam jennysylam@christensenir.com

July 24, 2022 10:59 PM Eastern Daylight Time

New Research Shows Positive Sentiment for Ron DeSantis Steady, No Fluke

Ready for Ron

Today, Ready for Ron, a draft committee encouraging Florida Governor Ron DeSantis to run for President, released research it commissioned from Impact Social showing positive sentiment amongst critical “floating voters” towards Governor DeSantis remains steady. Previous reports showed positive sentiment for Governor Ron DeSantis growing by more than 8 points from earlier analysis reports, indicating the gain is no fluke, but part of steady momentum. “It’s great to see positive sentiment towards Governor DeSantis staying high in these reports – despite an increasing drumbeat of attacks from the left,” stated Lilian Rodriguez-Baz, Chief Legal Counsel for Ready for Ron. “The response from our work to build grassroots support is impressive, and this research confirms the tremendous support we see on the ground. The positive feedback and engagement are significant and continue growing exponentially.” Ready for Ron launched an advertising and grassroots mobilization effort in late May to help convince Ron DeSantis he has the support to win the Presidency in 2024. The PAC also filed an official Advisory Opinion Request with the Federal Election Commission to ask if it may share its supporter list with Governor DeSantis to convince him to run and when – not if - he becomes a candidate. To generate the report released today, Impact Social researchers analyzed the publicly available social media discussion in relation to Ron DeSantis and Donald Trump among swing voters from June 29, 2022 to July 13, 2022. Additional reports are expected to continue every two weeks. Previous reports are available here. “We carried out detailed language analysis of US social media discussions back to May 2016 to capture social media users into a database of 40,000 swing voters,” explained Phil Snape, Director at Impact Social. “With 40,000 participants, we are operating what is likely the world’s largest focus group – as big as a Football stadium.” The summary of Impact Social’s second report states: This has been a difficult period for Donald Trump with net sentiment falling 11pts (-30 to -41) over the last two weeks. This should set off alarm bells in Mar-a-Largo. It has long been believed that Jan 6 divides people into two camps. Those who love Trump think his involvement in events that day are a nonsense, a witch hunt cooked up by his enemies desperate to bring him down and ensure he never runs again. Whereas those on the left are convinced of his guilt regardless of any evidence to the contrary. However this analysis shows that floating voters, particularly those on the right, are increasingly siding against him as new revelations of what happened on Jan 6 take their toll. This has resulted in an increase in the amount of posts stating that they are against Trump (+15pt- 31 to 46). Worryingly for team Trump are the low number of people on the right who are prepared to defend his actions. When discussing Jan 6 right leaning voters tend to pivot away from events and try to draw attention to other Trump ‘successes’ such as low unemployment or relative global peace. It is therefore fair to conclude that many on the right seem uncomfortable talking about the events of that day. It is also interesting to note how few floating voters speak about the ‘stolen election’. This conversation has been almost non-existent within this 40K panel since this analysis began six weeks ago, which begs the question of how many floating voters side with Trump and believe the Democrats stole the presidency? For his part Ron DeSantis seems to be coasting along. Despite being in the middle of a re-election campaign - which by design means that the candidate is duty bound to upset some voters in order to attract others - his net sentiment among floating voters remains consistent at -6. In fact, in contrast to Trump, the conversation over the period has remained largely the same with those in favor of his politics and style seeing him as a good governor, with a solid track record in office and their preferred candidate ahead of Trump for 2024. “We are excited to see our efforts paying off. Support for Ron DeSantis continues to grow, despite increasing attacks from the Left, and his base is solid,” Rodríguez-Baz continued. “We are building the biggest grassroots movements ever, and with support growing like this, it will happen even quicker than anticipated.” Ready for Ron continues its TV and online advertising efforts to engage Americans to sign the petition at www.ReadyForRon.com to Draft Ron DeSantis to run in 2024. “Despite reports to the contrary, the only war on former President Donald Trump, is coming from the radical left. All of us at Ready for Ron appreciate his leadership and effective policies that led to a booming economy, lower crime, and affordable gas prices. We are #ReadyforRon to carry these policies and the America First agenda forward,” Rodríguez-Baz said. Impact Social is a specialist social media, online monitoring, and analysis company. Its unique methodology ensures unrivalled accuracy to show what has been said and its impact. Impact Social is the only company in the world providing this high level of analysis. ### For more information or to schedule an interview with ‘Ready for Ron’ legal counsel, Lilian Rodríguez-Baz, or an Impact Social spokesperson, please contact Dan Rene at 202-329-8357 or dan@readyforron.com Contact Details Dan Rene +1 202-329-8357 dan@readyforron.com Company Website https://www.readyforron.com/

July 22, 2022 09:30 AM Eastern Daylight Time

Shortage of Mental Health Professionals Gets Severe

The Chicago School of Professional Psychology

At a time when we need them most, psychologists and other mental health professionals are harder to find—resulting in a severe shortage of behavior health providers in the U.S. Government agencies estimate half of those who need psychological services are not able to access them. “Many people who desperately need support are finding they have few options,” said Dr. Michele Nealon, Psy.D., President of The Chicago School of Professional Psychology. “At a time when more people need mental health counseling, we have fewer professionals to meet the need.” According to Dr. Nealon, the widening gap means that someone who needs counseling may have to wait months to see a specialist. In Los Angeles County, a national search last year to fill 83 vacant mental health positions yielded only 13 candidates, reports the Public Health Department. A Harvard University study recently found just 17 percent of phone calls placed to get an appointment with a mental health counselor were successful. The shortage, which has existed for more than a decade, has grown worse since the pandemic prompted thousands of therapists to take early retirement or leave the field entirely. This shortage is now exacerbated by a global 25 percent increase in depression, trauma, and anxiety resulting from the pandemic, inflation, war, and mass violence, according to the World Health Organization. The U.S. Health Resources and Services Administration reports that we “need to add 10,000 providers to each of seven separate mental healthcare professions by 2025 to meet the expected growth in demand.” “At The Chicago School, we are training more than 6,000 professionals every year to fill the need, especially in underserved communities of color and in rural areas,” said Dr. Nealon. “There needs to be a greater investment in this country in mental health institutions and prospective counselors so that we create a continuous pipeline to these communities.” The training for a psychologist or counselor typically requires two to five years of post-bachelor’s degree studies, so there will take time for the supply of new therapists to catch up with demand. With growing acceptance of mental health services, the gap is even greater for culturally competent therapists who understand specific communities, such as LGBTQIA+ and ethnic/racial minorities. “Two out of three students at The Chicago School identify as people of color,” Dr. Nealon noted. “These are the professionals who are most critical to addressing our mental health crisis in the long run.” About The Chicago School of Professional Psychology Integrating theory with hands-on experience, The Chicago School of Professional Psychology provides education rooted in a commitment to innovation, service, and community for thousands of diverse students across the United States and globally. Founded in 1979, the nonprofit, regionally accredited university now features campuses in iconic locations across the country (Chicago, Southern California, Washington, D.C., New Orleans, Dallas) and online. TCSPP continues to expand its educational offerings beyond the field of psychology to offer more than 30 degrees and certificates in the professional fields of health services, nursing, education, counseling, business, and more. Through its engaged professional model of education, commitment to diversity and inclusion, and an extensive network of international partner institutions, The Chicago School’s students receive real-world training opportunities that reflect their future careers. The Chicago School is a proud affiliate of TCS, a nonprofit system of colleges advancing student success and community impact. To learn more, visit www.thechicagoschool.edu. Contact Details The Chicago School of Professional Professional Psychology Vivien Hao +1 323-893-4743 vhao@thechicagoschool.edu

July 21, 2022 02:30 PM Pacific Daylight Time

US Digestive Health Expands Presence in Southwestern PA Through Partnership with Top-Rated Gastrointestinal Practice

US Digestive Health

US Digestive Health (USDH), a network of top-rated gastrointestinal (GI) practices managed by US Digestive Health Management (USDHM), a management services organization created to expand access to high-quality, low-cost gastroenterology care, announced today that it has partnered with Southwestern Gastrointestinal Specialists (SWGI), a specialty practice with full-service locations in Uniontown and Connellsville, PA. With the addition of this new partnership, US Digestive Health Management now oversees a network of gastroenterology providers and services with 26 locations, 15 ambulatory surgery centers, over 150 providers, and more than 800 employees. US Digestive Health Management works hand-in-hand with gastroenterology partner practices throughout Central and Southeastern Pennsylvania, the Greater Philadelphia region, and now Western Pennsylvania, to meet the challenges of a fast-changing healthcare landscape. USDHM provides innovative business management and technology solutions that ease administrative burdens and allows physicians to focus on clinical care. “By partnering with USDH, our team of board-certified GI doctors and specialists can stay focused on delivering high-quality patient care, prioritizing high standards in medicine, innovation in diagnosis, and treatment for patients,” said Dr. Frederick W. Ruthardt, President of Southwestern Gastrointestinal Specialists. “As we expand our footprint, our goal is to continue partnering with top GI practices that have exceptional reputations in their communities,” said Jerry Tillinger, CEO of US Digestive Health Management. “Southwestern Gastrointestinal Specialists’ commitment to providing patients with the latest advances in the gastroenterology field and their patient-focused care makes them a leader in this market, and we could not be more thrilled to partner with them.” USDHM was formed in 2019 by Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, in partnership with member practice partner physicians. Gabriel Luft, Partner at Amulet, commented, “We are excited to announce that US Digestive Health is partnering with another best-in-class GI practice that leads in prioritizing the patient experience, driving positive outcomes, and creating long-term value.” Luft added, “We are confident that increasing access to top-rated GI practices through our partnerships will benefit patients throughout Pennsylvania. Importantly, the expansion of USDH-backed practices into Southwestern Pennsylvania will provide both current and future patients with access to more innovative, quality healthcare options closer to home.” For more information, please visit https://usdigestivehealth.com/ About US Digestive Health US Digestive Health oversees a network of 140 gastroenterology providers and has 26 locations, 13 ambulatory surgery centers, and more than 700 total employees in Pennsylvania. They are at the forefront of the rapidly advancing science of digestive health, bringing new insight into the care, treatment, and prevention of digestive health disorders. About Amulet Capital Partners, LP Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. For additional information, please visit www.amuletcapital.com. Contact Details US Digestive Health Lauren Stralo +1 484-747-9692 lstralo@levlane.com Company Website https://usdigestivehealth.com

July 21, 2022 10:00 AM Eastern Daylight Time

Telland Releases First of Its Kind Farmland NFTs on Telos Blockchain

Telos Foundation

The mint is currently underway on Telos EVM providing users with a unique opportunity to own collectable artistic NFTs representing access to yields from 100 square meters of physical land within the Proyecto Ecológico Nuestro Paraíso in the Northwestern region of Piura, Peru, South America. However, the use-case of Telland NFTs goes far beyond simple ownership. These land plots will contribute to the growth of local farmers' sustainable organic produce and a more robust economy in the region. Perpetual Rewards for Holders Users that mint one or more Telland NFTs will receive annual rewards in perpetuity, financially backed by the revenue generated from the South American farmland. Currently there are only 100 NFT parcels of land priced at $150 USD in TLOS tokens each available to mint. The rewards payment breakdown is as follows: Year 1 of ownership - Holder receives minimum guarantee of $30 (20% APR on NFT mint price) Year 2 of ownership - Holder receives a minimum guarantee of $50 (33% APR on NFT mint price) Year 3 of ownership - Holder receives a minimum guarantee of $75 (50% APR on NFT mint price). This minimum continues perpetually from year 3 onwards. The collection debuts at an ideal moment as accumulating land ownership is more challenging for millennials today than at any other time in our history. Furthermore, Telland NFTs offers holders a chance to generate passive revenue from a real-world asset that benefits the environment while omitting painstaking bureaucratic processes and paperwork. Telland is also a participant in the Telos Mission NFT contest, which offers NFT creators a chance to win substantial prize money and acclaim in the NFT community. The contest has over 60 submissions to date and Telland's participation provides yet another opportunity for value increase in the event Telland is announced a winner. Public voting begins on July 23, 2002, on the TaiKai Network. "We chose Telos primarily for two factors: the community and the technology. The vision of the founders of Telos was to create a community around the ideas of service to society and care for the environment. Telland wants to do just that by converting arid lands into farmlands that produce fruits with a high nutritional content that help the well-being of humanity. In terms of technology, the ease of creating and deploying smart contracts in the Telos EVM, the incredible speed and low cost of transactions was such that the decision to build on their network was simple." -Paul Gonzales, Telland Co-founder "Telland is an amazing example of real-world application of NFTs and a glimpse at the future of tokenised land and real estate. At $150 an NFT, these prove to be a very interesting way to gain exposure to the value of real estate. The idea of being able to buy and trade land rights with such ease is magical to anyone who has had the pleasure of making a traditional real estate purchase where the process is incredibly slow (taking 2-4 weeks) and requiring middle men and costly fees" -Justin Giudici, Telos Foundation CEO About Telos Live since 2018, Telos Blockchain (ticker: TLOS) is an ESG compliant Layer 1 smart contract platform that offers full-service compatibility with Solidity, Vyper and Native C++ smart contracts. The Telos EVM is the most powerful and scalable Ethereum Smart Contract platform built to power Web 3.0. Telos features a robust, third-generation, ESG compliant evolutionary blockchain governance system, including smart contracts, advanced voting features, and flexible and user-friendly fee models. In addition, Telos supports the blockchain ecosystem by serving as an incubator and accelerator for decentralized applications through development grants. Come build with us. About The Foundation The Telos Foundation is a Decentralized Autonomous Organization established as a promotional and funding body to advance the Telos Blockchain Network and provide support to network applications. Contact Details The Team hello@telosfoundation.io Company Website https://www.telos.net/

July 19, 2022 10:06 AM Eastern Daylight Time

VinFuture Foundation launches science and technology webinar series “InnovaTalk 2022”

Vingroup

HANOI, VIETNAM - Media OutReach – 19 July 2022 - VinFuture Foundation officially launched a series of six InnovaTalk webinars focusing on key areas of science and technology to introduce new technology trends that may provide grounds for solutions to urgent global issues. The series was launched by the VinFuture Foundation with the goal of promoting the community-oriented values of science and technology, inspiring domestic and international scientists, especially young scientists, as well as sharing knowledge in an engaging and accessible way to science enthusiasts. The InnovaTalk webinar series includes six seminars taking place on Zoom from now until the end of November 2022. Each seminar will be led by a member of VinFuture’s scientific councils or a VinFuture Prize laureate. Invited guest speakers are leading international scientists from different high-tech fields and distinguished professors from top global universities and research institutes, such as the University of California system, University of Illinois Urbana-Champaign, University of Oxford, Stanford University, National University of Singapore, and other prominent universities. A highlight of the webinar series is the active participation of the Vietnamese scientific community with leading domestic scientists and experts from technology institutes and academies, as well as representatives from businesses, organizations, ministries, and departments. Through discussions and interactive activities, VinFuture Foundation expects to portray the meaningful roles and contributions of the Vietnamese scientific community in the global value chain. Sharing about the networking event series, Dr. Le Thai Ha – CEO of VinFuture Prize said: “ With the 2022 InnovaTalk series, we want to join hands to resolve global issues. Each webinar opens up an opportunity to connect science and technology communities, promote interaction and cooperation, and help accelerate the development of industries towards a healthy, modern, and sustainable society after the COVID-19 pandemic, following the "Reshaping and Reviving" theme of the 2022 VinFuture season." On June 29, the first webinar was successfully held with the theme of "High-tech Agriculture – Transgenic Livestock". The second InnovaTalk webinar is scheduled to take place on July 26, 2022 with the theme of "Cancer Measurement at the Point of Care". Professor Chi Van Dang, member of the VinFuture Prize Council, Scientific Director of Ludwig Institute for Cancer Research, USA, will chair the webinar. The webinar’s focus will be a presentation on methods and techniques to help develop precision cancer diagnosis technology from Professor Brian T. Cunningham - Intel Alumni Endowed Chair of the Department of Electrical and Computer Engineering, Director of Center for Pathogen Diagnostics, University of Illinois Urbana-Champaign. To listen to the speakers’ presentations, as well as participate in discussions and interactions in the second webinar with the theme of "Cancer Measurement at the Point of Care", interested viewers can register to join the webinar at: https://cloud.info.vinuni.edu.vn/vinfutureprize_innovatalk_2022_webinar_2 Through the webinar series, VinFuture aims to build a platform for more than 2,000 viewers to connect with science, exchange knowledge, and discuss with scientists and scholars about pressing global issues. InnovaTalk webinar series’ topics: 1. Webinar #1 (June): High-tech Agriculture – Transgenic Livestock 2. Webinar #2 (July): Cancer Measurement at the Point of Care 3. Webinar #3 (August): Artificial Intelligence 4. Webinar #4 (September): Green Energy 5. Webinar #5 (October): Advanced Materials 6. Webinar #6 (November): Environmental Sustainability About VinFuture Foundation The VinFuture Foundation, established on December 20th, 2020, on the occasion of International Human Solidarity Day, is an independent, not-for-profit foundation established by Mr. Phạm Nhật Vượng, the Chairman of Vingroup JSC, Vietnam’s leading private conglomerate, and his wife, Madam Phạm Thu Hương. The vision and mission of the Foundation are to create positive changes in the lives of millions of people in the world. The core activity of the Foundation is awarding the annual VinFuture Prizes to breakthrough scientific research and technological innovations that have already contributed or have the potential to contribute to the betterment of life for people. The VinFuture Prize consists of four prize categories, of which the Grand Prize – with a value of US$3 million – is one of the largest annual global prizes, and three additional Special Prizes, worth US$500,000 each, are dedicated to Female Innovators, Innovators from Developing Countries, and Innovators with Outstanding Achievements in Emerging Fields. In addition, the Foundation also conducts many activities to realize its mission, such as funding research, collaborating in academic development, and promoting STEM education. The 2021 VinFuture Prize Laureates The Grand Prize: Dr. Katalin Karikó, Prof. Drew Weissman (USA) and Prof. Pieter Cullis (Canada) with their breakthrough research on mRNA technology for vaccines. Special Prize for “Innovators with Outstanding Achievements in Emerging Fields”: Professor Omar Yaghi (USA) with his work on discovering Metal-Organic Framework Materials (MOFs) Special Prize for “Female Innovators”: Professor Zhenan Bao (USA) with her work on developing flexible electronics with the sensing properties of human skin. Special Prize for “Innovators from Developing Countries”: Prof. Salim S. Abdool Karim and Professor Quarraisha Abdool Karim (South Africa), for their Research on Pre-Exposure Prophylaxis with Antiretrovirals to prevent transmission of HIV. Contact Details Vingroup Media Contact v.nammh@vingroup.net

July 19, 2022 09:30 AM Eastern Daylight Time

Image

RDW Group Receives Five Bell Ringer Awards

RDW Group

RDW Group accepted a total of five Bell Ringer awards during the PR Club ’s 54th annual ceremony, held last month at the Royal Sonesta Boston. The Bell Ringer Awards recognize public relations and communications campaigns demonstrating excellence in planning, strategy, execution, and outcomes. RDW received awards for five campaigns and initiatives conducted throughout 2021: Business-to-Consumer (B2C) Social Media Silver Bell: RDW Group with Rhode Island Medical Imaging for “Sharing the Unseen Through Social Media” Bronze Bell: RDW Group with Ageless Innovation for “Supporting Caregivers and Older Adults Through Social Media” Mega Influencer Bronze Bell: RDW Group with Ageless Innovation for “Social Media Influencers Help Raise Awareness of Joy for All Companion Pets” Healthcare Campaign Bronze Bell: RDW Group with the Rhode Island Department of Health for the “Rhode Island Department of Health Substance Exposed Newborns Campaign” One-Time Special Event Merit: RDW Group with Rhode Island Medical Imaging for “Rhode Island Medical Imaging and Providence College Basketball Pink Out Friartown” “RDW is proud to, once again, be recognized alongside our clients as Bell Ringer recipients,” said RDW Group’s managing partner, Phil Loscoe, Jr. “The collaborative work of our teams is not only award-winning, but more importantly is proven to be making a positive impact on our communities. There is no better reward.” The Bell Ringer event was hosted by Brianna Borghi, on-air reporter for NBC5, Burlington, VT. In addition to the Bell Ringer awards, the Pub Club announced winners of its Striker and Ringer professional awards and its John J. Molloy Crystal Bell for lifetime achievement award. “The excellence of our New England PR community shines through in this year’s Bell Ringer Award winners,” said Amanda Fountain, PR Club president and digital engagement lead at LEGO Education. “This year feels extra special as we returned to celebrating the incredible work and professionals in-person after two years of virtual events. The format of the Bell Ringer presentation may have adapted to the times, but the quality of the work and dedication of the individuals who do it is consistently impressive.” View all 54 th annual Bell Ringer Award recipients at prclub.org/blog/54th-bell-ringer-awards-concludes. Learn more about RDW Group at rdwgroup.com. RDW Group was founded in 1986, and is a full-service advertising, public relations and media services agency with offices in Providence and Boston. RDW also operates iFactory, an award-winning web strategy, design and development group in Boston. More info at rdwgroup.com. Contact Details RDW Group Giselle Mahoney +1 401-829-8321 gmahoney@rdwgroup.com Company Website https://rdwgroup.com

July 19, 2022 09:13 AM Eastern Daylight Time

Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology

Elsevier

The Society for Mucosal Immunology (SMI), the preeminent international community of researchers working together to advance the field of mucosal immunology and improve health worldwide, and Elsevier, a global leader in research publishing and information analytics, are delighted to announce a new partnership to publish SMI’s official journal, Mucosal Immunology. The journal will transition to gold open access, making articles immediately and permanently available for everyone to read, download, copy and distribute. It will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2023. SMI’s decision to partner with Elsevier furthers its ongoing mission to directly support research and education and foster communication and collaboration in the field of mucosal immunology. Transitioning its journal from its current subscription model to gold open access clearly reflects its commitment to make its content more easily accessible and drive innovation in the field. SMI President Michael McGuckin, PhD, said: “We welcome Elsevier as our new publisher and look forward to taking advantage of its publishing expertise and commitment to open science as we continue our journey to increase the visibility and influence of Mucosal Immunology together. It is clear from our early interactions with Elsevier staff and leadership that this will be a partnership in the truest sense of the word and enable us to build upon the journal’s high standards and further enhance its global prominence.” Since 1990, mucosal immunology has expanded from what many considered a niche discipline to one of the hottest areas in immunobiology today, underpinned by interactions with the microbiome and nervous system that have profound implications for health and disease. The journal fosters cross-fertilization between scientists, clinical researchers and industry professionals across a broad spectrum of specialties working on pathways of immunity and inflammation at barrier surfaces. They rely on Mucosal Immunology for the very latest robust, cutting-edge original research and reviews in basic, translational and clinical science. The journal has earned a strong reputation for publishing papers based on the quality of the science, its rapid and rigorous peer review, and its contributions to advancing the field. This is demonstrated by its impressive 2021 Journal Impact Factor of 8.701* and a steadily increasing online and social media community. “The editorial board and I are tremendously excited for the opportunity to partner with Elsevier to publish Mucosal Immunology,” said Professor Marsland. “I have every confidence that support from the Elsevier team will foster even greater success in our ongoing efforts to publish novel, transformative, and clinically relevant science. On behalf of Mucosal Immunology ’s editors, editorial staff, reviewers, and authors, I want to welcome our new partner. Ben Marsland, PhD Elsevier is firmly committed to the continuity of the journal’s rigorous editorial process and accessibility of content, and further solidifying Mucosal Immunology ’s reputation. “We are delighted that SMI has selected Elsevier as its publishing partner. By combining their expertise with Elsevier’s industry-leading resources for authors, editors, peer reviewers and readers, we will ensure the best possible support for SMI’s mission and community. By working together, we can achieve a more inclusive, collaborative and transparent world of research,” stated Louise Curtis, Senior Vice President, Life Sciences & Social Sciences, at Elsevier. “ Mucosal Immunology is a great asset to the Elsevier immunology journal portfolio, and we look forward to helping the society and their journal navigate a successful transition to full open access status,” added Jenny Henzen, Elsevier’s Publisher for Immunology. *Journal Citation Reports, Clarivate, 2022 About Mucosal Immunology Mucosal Immunology is the official publication of the Society for Mucosal Immunology (SMI). It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving barrier tissues. The journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, genitourinary and skin immunology through the publication of original research articles, scholarly reviews, and timely commentaries. Publication of basic, translational, and clinical studies are given equal consideration. In addition, Mucosal Immunology aims to provide a primary method of communication for the SMI governing board and its members through the publication of society news, announcements of planned meetings and conferences, discussions of policy concerns, and advertisements for job and training opportunities. Beginning January 2023, all articles will be published as gold open access through CC BY licenses. About the Society for Mucosal Immunology (SMI) The Society for Mucosal Immunology was formed in 1987 to advance research and education related to the field of mucosal immunology. With a mission to support research and education, and foster communication and collaboration in the field of mucosal immunology, the society represents a diverse group of over 700 scientists and clinicians from all over the world. https://www.socmucimm.org About the Editor-in-Chief Ben Marsland completed his PhD in Immunology at Otago University and the Malaghan Institute of Medical Research, Wellington, New Zealand. He then spent 14 years in Switzerland, first at the ETH Zürich and then as a Cloetta Medical Research Fellow at the University Hospital of Lausanne (CHUV). During that period, he received the ETH Latsis Prize, the Leenaards Prize and the ERS COPD Research Award. Since 2018, Ben is a veski innovation fellow, NHMRC Senior Research Fellow and Professor in the Department of Immunology and Pathology within the Central Clinical School at Monash University. He also maintains a visiting professorship at the University of Lausanne and CHUV. The focus of Ben’s lab revolves around the microbiome in the gut, lung and skin and how it influences asthma, respiratory viral infections and lung fibrosis. About Elsevier and society partnerships Elsevier has long-standing partnerships with over 600 learned societies worldwide, helping them to realize their missions and inspire and support their communities. We pride ourselves on consistently delivering outstanding publishing outcomes through strategic insight, reliable finances, global dissemination, embracing open science and open access, and championing the needs of the communities we jointly serve. www.elsevier.com/societies About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details Elsevier Jenny Henzen, Publisher, Immunology j.henzen@elsevier.com Company Website https://www.elsevier.com/

July 18, 2022 04:00 AM Eastern Daylight Time

Image

1 ... 215 216 217 218 219 ... 307